This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products.View INSY key stats
Insys Therapeutics Inc - INSY - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Insys Therapeutics Inc as a
Buy with a ratings score of B.
Report Snippet: We rate INSYS THERAPEUTICS INC (INSY) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.